- Hovione has partnered with Microinnova Engineering to test modular, plug-and-play equipment for flow chemistry in an industrial setting.
- The collaboration aims to improve flexibility, scalability, efficiency, and sustainability in drug substance production.
Hovione and Microinnova Engineering have announced a partnership to advance the development and testing of modular manufacturing equipment for flow chemistry. The collaboration focuses on creating multi-purpose, plug-and-play equipment designed to enhance process development and accelerate the transition from lab-scale to large-scale pharmaceutical manufacturing.
The Microinnova equipment will be trialled in Hovione’s industrial environment, offering greater flexibility, easier scalability, improved efficiency, and sustainable practices in active ingredient production. The partnership is intended to reduce time to market for pharmaceutical customers by streamlining continuous manufacturing processes.
“This collaboration with Microinnova underscores Hovione’s commitment to innovation in pharmaceutical manufacturing, with flow chemistry playing an important role in our long-term drug substance strategy. This partnership will allow us to shape and validate emerging continuous manufacturing technologies, which can potentially accelerate drug development and production.”
Dr. Jean-Luc Herbeaux, CEO of Hovione
Dr. Dirk Kirschneck, Founder and Strategic Director at Microinnova, added that the partnership highlights a shared vision to deliver modular manufacturing technologies that support pharmaceutical innovation and manufacturing excellence. He noted that showcasing these technologies in a CDMO environment demonstrates their versatility for multi-purpose manufacturing.
